Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Scirica BM, Mosenzon O, Bhatt DL, Udell JA, Steg PG, McGuire DK, Im K, Kanevsky E, Stahre C, Sjöstrand M, Raz I, Braunwald E.

JAMA Cardiol. 2017 Dec 6. doi: 10.1001/jamacardio.2017.4228. [Epub ahead of print]

PMID:
29214305
2.

Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest.

Sarak B, Goodman SG, Brieger D, Gale CP, Tan NS, Budaj A, Wong GC, Huynh T, Tan MK, Udell JA, Bagai A, Fox KAA, Yan AT; Global Registry of Acute Coronary Events (GRACE) Investigators and the Canadian Acute Coronary Syndromes I Investigators.

Am J Cardiol. 2017 Nov 3. pii: S0002-9149(17)31687-9. doi: 10.1016/j.amjcard.2017.10.030. [Epub ahead of print]

PMID:
29197473
3.

Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Co-Transporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study.

Udell JA, Yuan Z, Rush T, Sicignano NM, Galitz M, Rosenthal N.

Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.031227. doi: 10.1161/CIRCULATIONAHA.117.031227. [Epub ahead of print]

PMID:
29133607
4.

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI.

Circulation. 2017 Oct 24;136(17):1643-1658. doi: 10.1161/CIRCULATIONAHA.117.030012. Review.

PMID:
29061576
5.

Preoperative Intraaortic Balloon Pump Improves Early Outcomes Following High-Risk Coronary Artery Bypass Graft Surgery: A Meta-Analysis of Randomized Trials and Prospective Study Design.

Rampersad PP, Udell JA, Zawi R, Ouzounian M, Overgaard CB, Sharma V, Rao V, Farkouh ME, Džavík V.

J Invasive Cardiol. 2017 Sep 15. pii: JIC2017915-1. [Epub ahead of print]

6.

Cardiovascular Risk Following Fertility Therapy: Systematic Review and Meta-Analysis.

Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T, Basso O, Udell JA.

J Am Coll Cardiol. 2017 Sep 5;70(10):1203-1213. doi: 10.1016/j.jacc.2017.07.753. Review.

PMID:
28859782
7.

Improving the Appropriate Use of Transthoracic Echocardiography: The Echo WISELY Trial.

Bhatia RS, Ivers NM, Yin XC, Myers D, Nesbitt GC, Edwards J, Yared K, Wadhera RK, Wu JC, Kithcart AP, Wong BM, Hansen MS, Weinerman AS, Shadowitz S, Elman D, Farkouh ME, Thavendiranathan P, Udell JA, Johri AM, Chow CM, Hall J, Bouck Z, Cohen A, Thorpe KE, Rakowski H, Picard MH, Weiner RB.

J Am Coll Cardiol. 2017 Aug 29;70(9):1135-1144. doi: 10.1016/j.jacc.2017.06.065.

PMID:
28838362
8.

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.

Gong IY, Goodman SG, Brieger D, Gale CP, Chew DP, Welsh RC, Huynh T, DeYoung JP, Baer C, Gyenes GT, Udell JA, Fox KAA, Yan AT; Canadian GRACE/GRACE-2 and CANRACE Investigators.

Int J Cardiol. 2017 Oct 1;244:24-29. doi: 10.1016/j.ijcard.2017.06.055. Epub 2017 Jun 15.

PMID:
28645803
9.

Regional variations in ambulatory care and incidence of cardiovascular events.

Tu JV, Chu A, Maclagan L, Austin PC, Johnston S, Ko DT, Cheung I, Atzema CL, Booth GL, Bhatia RS, Lee DS, Jackevicius CA, Kapral MK, Tu K, Wijeysundera HC, Alter DA, Udell JA, Manuel DG, Mondal P, Hogg W; Cardiovascular Health in Ambulatory Care Research Team (CANHEART).

CMAJ. 2017 Apr 3;189(13):E494-E501. doi: 10.1503/cmaj.160823.

10.

Failure of fertility therapy and subsequent adverse cardiovascular events.

Udell JA, Lu H, Redelmeier DA.

CMAJ. 2017 Mar 13;189(10):E391-E397. doi: 10.1503/cmaj.160744.

11.

The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors.

Secrest MH, Udell JA, Filion KB.

Trends Cardiovasc Med. 2017 Apr;27(3):194-202. doi: 10.1016/j.tcm.2017.01.009. Epub 2017 Jan 28. Review.

PMID:
28291655
12.
13.

Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization.

Udell JA, Koh M, Qiu F, Austin PC, Wijeysundera HC, Bagai A, Yan AT, Goodman SG, Tu JV, Ko DT.

J Am Heart Assoc. 2017 Jan 20;6(1). pii: e004319. doi: 10.1161/JAHA.116.004319.

14.
15.

Cardiovascular Risk Factor Management Performance in Canada and the United States: A Systematic Review.

Alabousi M, Abdullah P, Alter DA, Booth GL, Hogg W, Ko DT, Manuel DG, Farkouh ME, Tu JV, Udell JA.

Can J Cardiol. 2017 Mar;33(3):393-404. doi: 10.1016/j.cjca.2016.07.005. Epub 2016 Jul 18. Review.

PMID:
27876171
16.

Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success-a meta-analysis.

Goldenberg GR, Burd D, Lodzinski P, Stabile G, Udell JA, Newman D, Shurrab M, Crystal E.

J Interv Card Electrophysiol. 2016 Nov;47(2):171-176. Epub 2016 Jun 29. Review.

PMID:
27357216
17.

Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.

Scirica BM, Bhatt DL, Braunwald E, Raz I, Cavender MA, Im K, Mosenzon O, Udell JA, Hirshberg B, Pollack PS, Steg PG, Jarolim P, Morrow DA.

JAMA Cardiol. 2016 Dec 1;1(9):989-998. doi: 10.1001/jamacardio.2016.3030.

PMID:
27681000
18.

Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.

Fitchett DH, Udell JA, Inzucchi SE.

Eur J Heart Fail. 2017 Jan;19(1):43-53. doi: 10.1002/ejhf.633. Epub 2016 Sep 21. Review.

PMID:
27653447
20.

Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.

Bagai A, Bhatt DL, Eikelboom JW, Mancini GB, Cohen EA, Vijayaraghavan R, Cheema AN, Udell JA, Niznick J, Tanguay JF, Verma S, Mehta SR.

Circulation. 2016 May 24;133(21):2094-8. doi: 10.1161/CIRCULATIONAHA.115.021158. Review. No abstract available.

Supplemental Content

Loading ...
Support Center